We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+11.1%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$79B
AUM Growth
+$5.52B
(+7.5%)
Cap. Flow
-$7.01B
Cap. Flow
% of AUM
-8.87%
Top 10 Holdings %
Top 10 Hldgs %
24.46%
Holding
2,559
New
284
Increased
737
Reduced
832
Closed
260
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chubb
CB
|
+$555M |
| 2 |
American Electric Power
AEP
|
+$272M |
| 3 |
Ulta Beauty
ULTA
|
+$161M |
| 4 |
CVS Health
CVS
|
+$160M |
| 5 |
McDonald's
MCD
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$388M |
| 2 |
Aon
AON
|
+$211M |
| 3 |
Johnson & Johnson
JNJ
|
+$209M |
| 4 |
Norfolk Southern
NSC
|
+$162M |
| 5 |
Envista
NVST
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.99% |
| 2 | Financials | 14.12% |
| 3 | Healthcare | 13.38% |
| 4 | Industrials | 11.48% |
| 5 | Consumer Discretionary | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Biogen
BIIB
$30.5B
| $6.5M | 0.01% |
25,136
-692
| -3% | -$170K |
|
|
SWZ
502
Swiss Helvetia Fund
SWZ
$77.1M
| $6.47M | 0.01% |
789,546
-12,879
| -2% | -$98.2K |
|
503
PACCAR
PCAR
$69.5B
| $6.31M | 0.01% |
64,670
-11,386
| -15% | -$1.02M |
|
504
Invesco QQQ Trust
QQQ
$479B
| $6.28M | 0.01% |
15,342
-813
| -5% | -$309K |
|
505
Rayonier
RYN
$6.45B
| $6.17M | 0.01% |
203,500
+34,056
| +20% | +$910K |
|
506
Neurocrine Biosciences
NBIX
$16.2B
| $6.12M | 0.01% |
46,445
+19,192
| +70% | +$2.21M |
|
507
Valmont Industries
VMI
$9.5B
| $6.11M | 0.01% |
26,164
+522
| +2% | +$115K |
|
508
CRISPR Therapeutics
CRSP
$4.99B
| $6.08M | 0.01% |
97,080
-18,434
| -16% | -$1.02M |
|
509
Hasbro
HAS
$12.9B
| $6.02M | 0.01% |
117,843
+1,500
| +1% | +$75.8K |
|
510
Palo Alto Networks
PANW
$293B
| $5.96M | 0.01% |
40,456
-141,446
| -78% | -$18.9M |
|
511
Danaos Corp
DAC
$2.61B
| $5.88M | 0.01% |
79,419
-8,119
| -9% | -$552K |
|
512
DexCom
DXCM
$31.3B
| $5.83M | 0.01% |
47,005
+640
| +1% | +$65.4K |
|
513
Vanguard S&P 500 ETF
VOO
$1.01T
| $5.79M | 0.01% |
13,264
+9,355
| +239% | +$3.83M |
|
514
Onto Innovation
ONTO
$13.4B
| $5.77M | 0.01% |
37,754
+36,049
| +2,114% | +$4.85M |
|
515
BGC Group
BGC
$4.97B
| $5.77M | 0.01% |
798,761
-547,890
| -41% | -$3.39M |
|
516
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
| – | – |
0
| – | – |
|
|
CTLT
517
DELISTED
CATALENT, INC.
CTLT
| $5.64M | 0.01% |
125,653
-5,083
| -4% | -$206K |
|
518
Brixmor Property Group
BRX
$9.25B
| $5.62M | 0.01% |
241,707
-13,624
| -5% | -$293K |
|
|
SWAV
519
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $5.61M | 0.01% |
29,468
+2,654
| +10% | +$502K |
|
520
White Mountains Insurance
WTM
$5.3B
| $5.58M | 0.01% |
3,706
-571
| -13% | -$849K |
|
521
Bank of America Series L
BAC.PRL
$3.98B
| $5.58M | 0.01% |
4,627
| – | – |
|
522
Northrop Grumman
NOC
$80.7B
| $5.57M | 0.01% |
11,905
-153
| -1% | -$71.7K |
|
523
Xylem
XYL
$28.2B
| $5.45M | 0.01% |
47,681
-908
| -2% | -$90.6K |
|
524
Molina Healthcare
MOH
$10B
| $5.43M | 0.01% |
15,035
-2,017
| -12% | -$711K |
|
525
Teradata
TDC
$2.54B
| $5.42M | 0.01% |
124,532
-53,917
| -30% | -$2.42M |
|
Similar funds
QCM
Lazard Asset Management's Q4 2023 Portfolio in Review
As of Q4 2023, Lazard Asset Management held 2,559 positions worth $79B, up 7.5% from $73.5B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Lazard Asset Management withdrew a net $7.01B in Q4 2023, closing 260 positions and reducing 832 holdings. Its most notable exit was VMware, Inc, an estimated $34.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Lazard Asset Management opened a new position in Dentsply Sirona worth $141M.
- Lazard Asset Management's largest Q4 2023 buy was Dentsply Sirona: 3,954,444 shares worth $141M.
- Lazard Asset Management added most to Chubb in Q4 2023, an estimated $555M increase.
- Lazard Asset Management's biggest Q4 2023 reduction was Meta Platforms (Facebook), cutting an estimated $388M.
- Lazard Asset Management fully exited VMware, Inc in Q4 2023, selling an estimated $34.5M.
- Lazard Asset Management's ten largest holdings make up 24% of its $79B portfolio in Q4 2023.
- Lazard Asset Management opened 284 new positions and closed 260 in Q4 2023.
- Lazard Asset Management's portfolio value rose 7.5% quarter-over-quarter to $79B.
Based on Lazard Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.